The 12 largest MSOs are ranked here as to their stock performances since the beginning of March and YTD, their likelihood of Financial Distress within the next 2 years, their average 12-month Price Targets, the extent of Short Interest and Insider Ownership.
Read More »Here’s How the 5 Cannabis Categories Performed Last Week
In summary, the 5 cannabis/cannabis-related company stock category performances ranged from: -4.4% to -14.3% YTD.
Read More »Canadian Cannabis LP Index: Analyst Forecasts Represent 65% Upside
On average, the 12-month forecasts represent an increase of 65% but so far their YTD percentages are universally down.
Read More »The 7 Largest Psychedelic Stocks: An Update
The 7 largest psychedelic drug stocks are ranked as to their stock performances since the beginning of March and year-to-date, their likelihood of financial distress, analyst price forecasts and the extent of short interest and insider ownership.
Read More »A “Rags-to-Riches” Portfolio Update
This article tracks the performance of the largest Canadian cannabis LPs, American cannabis MSOs, psychedelic drug stocks and plant-based food stocks in four separate munKNEE indexes on a weekly basis and this is an update on how the various categories in the Portfolio, and their constituents, have performed month-to-date (MTD) and year-to-date (YTD).
Read More »The “Multi-Bagger” Portfolio Performance: Month-to-Date; YTD
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 - DOWN 73% vs. 2021 - but perhaps some of them will bounce back with major - dare I say "multi-bagger" - returns in 2023.
Read More »Incannex Healthcare: Has World’s Largest Pipeline Of Psychedelic Programs
Incannex has the world’s largest portfolio of patented medicinal cannabis drug formulations with 28 clinical and pre-clinical research and development projects in its pipeline which have a combined global addressable market of approximately US$400B per annum.
Read More »666% Increase In Major Psychedelic Stocks Forecast By End Of 2023!
The 7 largest psychedelic drug stocks are ranked below as to their likelihood of Financial Distress within the next 2 years, their average year-end price targets as well as their stock performances last week and since the end of January.
Read More »Canadian Cannabis LPs Collapse Continues: – 13% This Week; -26% In Last 6 Weeks
To help you with your investment decisions, this article presents the stock performance of each of the 5 largest Canadian cannabis licensed producers (LPs) in the munKNEE Canadian Cannabis LPs Index this week and in the last 6 weeks in descending order,
Read More »American Cannabis MSOs Fell 8% Last Week; -19% In Last 6 Weeks
This article presents the stock performance of each of the 12 largest American cannabis multi-state operators (MSOs) in the munKNEE American Cannabis MSOs Index this week and in the last 6 weeks.
Read More »